SEI Investments’s Indivior Pharmaceuticals INDV Stock Holding History
Bought
Maintained
Sold
Other funds holding INDV
OCM
TSC
SEI Investments's INDV Position: Q2 2026 in Review
SEI Investments reduced its Indivior Pharmaceuticals (INDV) stake by 42% in Q2 2026, selling an estimated $2.51M and leaving 94,933 shares worth $3.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1626.
SEI Investments first reported a position in INDV in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.03M in Q4 2025. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.
- SEI Investments held 94,933 shares of Indivior Pharmaceuticals worth $3.9M as of Q2 2026.
- SEI Investments sold 69,281 Indivior Pharmaceuticals shares in Q2 2026, an estimated $2.51M.
- Indivior Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1626 holding.
- SEI Investments first reported a position in Indivior Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- SEI Investments's Indivior Pharmaceuticals position peaked at $7.03M in Q4 2025.
- 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.